Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:clinical_trial
|
| gptkbp:clinicalTrials.gov_Identifier |
NCT04449029
|
| gptkbp:condition |
gptkb:Chronic_Hepatitis_B
|
| gptkbp:fullName |
Efficacy and Safety of Bepirovirsen in Participants With Chronic Hepatitis B Virus Infection
|
| https://www.w3.org/2000/01/rdf-schema#label |
EPI-B
|
| gptkbp:intervention |
Bepirovirsen
|
| gptkbp:period |
Phase 2b
|
| gptkbp:sponsor |
GlaxoSmithKline
|
| gptkbp:startDate |
2020
|
| gptkbp:status |
Recruiting
|
| gptkbp:studyType |
Interventional
|
| gptkbp:bfsParent |
gptkb:Epiroc
|
| gptkbp:bfsLayer |
7
|